Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.

Antineoplastic Combined Chemotherapy Protocols / adverse effects Brentuximab Vedotin Granulocyte Colony-Stimulating Factor / therapeutic use Hodgkin Disease / drug therapy Humans Vinblastine / therapeutic use
Hodgkin lymphoma brentuximab vedotin frontline therapy growth factor primary prophylaxis

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 28 8 2020
medline: 28 4 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

We investigate the impact of granulocyte-colony stimulating factor (G-CSF) primary prophylaxis (G-PP,

Identifiants

DOI: 10.1080/10428194.2020.1791846 PMID: 32842815
pubmed: 32842815
doi: 10.1080/10428194.2020.1791846
doi:

Substances chimiques

Granulocyte Colony-Stimulating Factor 143011-72-7
Vinblastine 5V9KLZ54CY
Brentuximab Vedotin 7XL5ISS668

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2931-2938

Auteurs

David Straus (D)

Memorial Sloan Kettering Cancer Center, New York City, NY, USA.

Graham Collins (G)

Oxford Cancer and Hematology Center, Churchill Hospital, Oxford, UK.

Jan Walewski (J)

Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.

Pier Luigi Zinzani (PL)

Institute of Hematology Seragnoli, University of Bologna, Bologna, Italy.

Andrew Grigg (A)

Department of Clinical Haematology, Austin Hospital, Melbourne, Australia.

Anna Sureda (A)

Institut Català d'Oncologia-Hospitalet, Hospital Quirón Dexeus, Barcelona, Spain.

Arpad Illes (A)

University of Debrecen, Faculty of Medicine, Debrecen, Hungary.

Tae Min Kim (TM)

Seoul National University Hospital, Seoul, Republic of Korea.

Sergey Alekseev (S)

Petrov Research Institute of Oncology, St. Petersburg, Russia.

Lena Specht (L)

Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Valeria Buccheri (V)

Hematology Service, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

Anas Younes (A)

Memorial Sloan Kettering Cancer Center, New York City, NY, USA.

Joseph Connors (J)

BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada.

Andres Forero-Torres (A)

Seattle Genetics, Bothell, WA, USA.

Keenan Fenton (K)

Seattle Genetics, Bothell, WA, USA.

Ashish Gautam (A)

Millennium Pharmaceuticals, Cambridge, MA, USA.

Indra Purevjal (I)

Millennium Pharmaceuticals, Cambridge, MA, USA.

Rachael Liu (R)

Millennium Pharmaceuticals, Cambridge, MA, USA.
ORCID: 0000-0001-6033-4510

Andrea Gallamini (A)

Research and Clinical Innovation, Antoine-Lacassagne Cancer Center, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Protocoles de polychimiothérapie antinéoplasique › Primary prophylaxis with G-CSF may improve...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux humanisés › Brentuximab védotine › Primary prophylaxis with G-CSF may improve...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de croissance hématopoïétique › Facteurs de stimulation des colonies › Facteur de stimulation des colonies de granulocytes › Primary prophylaxis with G-CSF may improve...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Maladie de Hodgkin › Primary prophylaxis with G-CSF may improve...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Primary prophylaxis with G-CSF may improve...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indolizine › Indolizidines › Alcaloïdes indoliques › Alcaloïdes formés par condensation de sécologanine et de tryptamine › Alcaloïdes de Vinca › Vinblastine › Primary prophylaxis with G-CSF may improve...